Pi3k-gamma inhibitor ipi-549 Uses, Dosage, Side Effects and more
Pi3k-gamma inhibitor ipi-549 is under investigation in clinical trial NCT03795610 (Window of Opportunity Study of Pi3k-gamma inhibitor ipi-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma).
| Trade Name | Pi3k-gamma inhibitor ipi-549 |
| Generic | IPI-549 |
| IPI-549 Other Names | Pi3k-gamma inhibitor ipi-549 |
| Type | |
| Formula | C30H24N8O2 |
| Weight | Average: 528.576 Monoisotopic: 528.202222045 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
